Could insulin eye drops save your sight? new trial launches

NCT ID NCT07619482

Not yet recruiting Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether insulin eye drops can protect the optic nerve in people with open-angle glaucoma. Researchers will give 90 participants either insulin drops or placebo daily for up to 12 months. The main goal is to check safety, but they will also measure vision changes and eye structure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: topical sterile human insulin eye drops (EYED-002)
What this could lead to: If successful, this could provide a new way to protect the optic nerve and slow vision loss in glaucoma patients.
What could go wrong: This is an early-phase trial focused on safety, so it may not show clear benefit. Insulin eye drops could cause eye irritation or affect blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW TENSION GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exfoliation syndrome glaucoma low tension glaucoma open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW TENSION GLAUCOMA OPEN-ANGLE GLAUCOMA PIGMENTARY GLAUCOMA PRIMARY OPEN ANGLE GLAUCOMA PSEUDOEXFOLIATION GLAUCOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Byers Eye Institute at Stanford University

Palo Alto, California, 94303, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.